Ekbom Spectrum Psychosis Associated with 24-hour Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in Parkinson's Disease.
Continuous subcutaneous foslevodopa/foscarbidopa infusion (CSFLI) is an emerging treatment for advanced Parkinson's disease (PD). We report atypical psychosis with Ekbom-like somatic hallucinations during CSFLI. A 74-year-old man with a 16-year history of PD (Hoehn and Yahr stage 3), mild cognitive impairment (Montreal...